Thursday, January 12, 2017

Pharma Reviews: Pharma Q3: FDA inspection, US pricing market key

Pharmaceutical companies in India are expected to post muted results for the third quarter ended December 31, 2016. Piyush Nahar and Anurag ...
Read more: Pharma Q3: FDA inspection, US pricing market key